Capital Fund Management S.A. Biogen Inc. Put Options Transaction History

Capital Fund Management S.A.

$36 Billion
Q3 2024

Put Options

20 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 13, 2024	SELL	$189.07 - $236.8 $7.47 Million - $9.35 Million	-39,500 Reduced 48.71%	41,600 $8.06 Million
Q2 2024 Aug 13, 2024	BUY	$190.52 - $236.72 $9.6 Million - $11.9 Million	50,400 Added 164.17%	81,100 $18.8 Million
Q1 2024 May 15, 2024	SELL	$212.02 - $267.71 $3.58 Million - $4.52 Million	-16,900 Reduced 35.5%	30,700 $6.62 Million
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $6.97 Million - $8.39 Million	31,300 Added 192.02%	47,600 $12.3 Million
Q3 2023 Nov 14, 2023	BUY	$253.3 - $285.89 $4.13 Million - $4.66 Million	16,300 New	16,300 $4.19 Million
Q1 2023 May 15, 2023	BUY	$256.56 - $292.34 $230,904 - $263,106	900 Added 6.72%	14,300 $3.98 Million
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $4.63 Million - $6.39 Million	-23,800 Reduced 63.98%	13,400 $3.58 Billion
Q2 2022 Aug 12, 2022	BUY	$187.54 - $223.02 $675,144 - $802,872	3,600 Added 10.71%	37,200 $7.59 Million
Q1 2022 May 12, 2022	BUY	$193.77 - $244.14 $3.88 Million - $4.88 Million	20,000 Added 147.06%	33,600 $7.08 Million
Q1 2020 May 13, 2020	BUY	$268.85 - $341.04 $2.18 Million - $2.76 Million	8,100 Added 147.27%	13,600 $4.3 Million
Q4 2019 Feb 13, 2020	BUY	$220.06 - $304.07 $616,168 - $851,396	2,800 Added 103.7%	5,500 $1.63 Million
Q3 2019 Nov 13, 2019	SELL	$217.44 - $243.88 $1.7 Million - $1.9 Million	-7,800 Reduced 74.29%	2,700 $629,000
Q2 2019 Aug 12, 2019	BUY	$219.29 - $241.72 $1.18 Million - $1.31 Million	5,400 Added 105.88%	10,500 $2.46 Million
Q1 2019 May 13, 2019	SELL	$216.71 - $338.96 $7.87 Million - $12.3 Million	-36,300 Reduced 87.68%	5,100 $1.21 Million
Q4 2018 Feb 13, 2019	SELL	$278.5 - $352.75 $32.6 Million - $41.3 Million	-117,000 Reduced 73.86%	41,400 $12.5 Million
Q3 2018 Nov 14, 2018	SELL	$293.51 - $383.83 $93 Million - $122 Million	-317,000 Reduced 66.68%	158,400 $56 Million
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $66.6 Million - $79.4 Million	258,700 Added 119.38%	475,400 $138 Million
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $41.4 Million - $58.5 Million	159,000 Added 275.56%	216,700 $59.3 Million
Q4 2017 Feb 09, 2018	BUY	$307.64 - $344.58 $6.21 Million - $6.96 Million	20,200 Added 53.87%	57,700 $18.4 Million
Q3 2017 Nov 13, 2017	BUY	$281.15 - $329.69 $10.5 Million - $12.4 Million	37,500	37,500 $11.7 Million

Others Institutions Holding BIIB

# of Institutions

1,032

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Capital Fund Management S.A. with notifications on news.

Account